Other languages Xeris Biopharma Holdings, Inc.

Equities

XERS

US98422E1038

Delayed Nasdaq Other stock markets 03:59:08 2024-05-29 pm EDT			5-day change	1st Jan Change
1.945 ^USD	+1.30%		-2.99%	-17.02%

May. 09	Transcript : Xeris Biopharma Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024
May. 09	Earnings Flash (XERS) XERIS BIOPHARMA HOLDINGS Reports Q1 Revenue $40.6M, vs. Street Est of $41.8M	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xeris Biopharma Holdings, Inc. Provides Revenue Guidance for the Full Year 2024	May. 09
Xeris Biopharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09
Xeris Biopharma Collaborating With Beta Bionics for Development, Commercialization of Glucagon Product	May. 06
Xeris Biopharma Holdings, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 06
Xeris Biopharma Holdings, Inc. Provides Earnings Guidance for the Year 2024	Mar. 06
Xeris Biopharma Holdings Seeks Acquisitions	Jan. 11
US Equity Markets Close Higher Wednesday as Investors Await Inflation Data	Jan. 10
Sector Update: Health Care Stocks Gain Late Afternoon	Jan. 10
Xeris Biopharma Shares Rise on Licensing Agreement With Amgen	Jan. 10
Xeris Biopharma Enters into an Exclusive Worldwide License Agreement for Xeriject Formulation of Teprotumumab	Jan. 10
Sector Update: Health Care Stocks Stronger Late Afternoon	Jan. 04
Sector Update: Health Care Stocks Gain Thursday Afternoon	Jan. 04
Sector Update: Health Care	Jan. 04
Xeris Biopharma Expects 2023 Revenue to be at High End of Previous Guidance; Shares Jump	Jan. 04
Xeris Biopharma Holdings, Inc. Provides Revenue Guidance for the Year 2024	Jan. 04
Xeris Biopharma Holdings, Inc. Revises Revenue Guidance for the Year 2023	Jan. 04
Xeris Biopharma Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Xeris Biopharma Holdings, Inc. Revises Revenue Guidance for the Full Year 2023	Nov. 09
Investors Await Fed Decision as US Futures Move Lower in Wednesday's Premarket Activity	Nov. 01
Top Premarket Gainers	Nov. 01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Xeris Biopharma Holdings, Inc.

Equities

XERS

US98422E1038

Other languages

Filters